Report: Tracking system needed to fight fake drugs

February 13, 2013 by Lauran Neergaard

(AP)—A new report calls for a national drug tracking system to fight the growing problem of fake drugs.

The Institute of Medicine says phony or substandard drugs are an increasing international threat, and one that is affecting the U.S. as well.

Just last week, the warned doctors—for the third time in about a year—that it discovered a counterfeit batch of the cancer drug Avastin, one that lacks the real tumor-killing ingredient.

Wednesday's report says mandatory drug tracking would offer the same kind of reliability for medications that the U.S. court system's chain-of-custody requirements do for evidence used in trials. It would allow verification that a drug and the ingredients used to make it are authentic at every step.

Explore further: Roche warns of counterfeit cancer drug in US

shares

Related Stories

US warns of new fake batch of cancer drug Avastin

February 6, 2013

The Food and Drug Administration is warning U.S. doctors about another counterfeit version of the cancer drug Avastin, the third case involving the best-selling Roche drug in the past year.

Fake Avastin contained several chemicals, no drug

February 28, 2012

(AP) -- Counterfeit versions of the popular cancer drug Avastin obtained by European regulators contain a variety of chemicals, but not the active ingredient found in the genuine drug, according to drugmaker Roche.

FDA finds more vials of fake cancer drug

April 4, 2012

(AP) -- The Food and Drug Administration is warning doctors that a second counterfeit version of the best-selling cancer drug Avastin has been found in the U.S., packaged as the Turkish brand of the medication.

FDA warns of fake version of ADHD drug Adderall

May 30, 2012

(HealthDay) -- A counterfeit version of the attention-deficit/hyperactivity disorder drug Adderall, sold online, contains the wrong active ingredients, according to the U.S. Food and Drug Administration.

Recommended for you

Researchers identify source of opioids' side effects

January 17, 2017

A commercially available drug may help drastically reduce two side effects of opioid painkillers—a growing tolerance and a paradoxical increased sensitivity to pain—without affecting the drugs' ability to reduce pain, ...

CVS generic competitor to EpiPen, sold at a 6th the price

January 12, 2017

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to ...

Many misuse OTC sleep aids: survey

December 29, 2016

(HealthDay)—People struggling with insomnia often turn to non-prescription sleep remedies that may be habit-forming and are only intended for short-term use, according to a new Consumer Reports survey.

The pill won't kill your sexual desire, researchers say

December 15, 2016

Taking the pill doesn't lower your sexual desire, contrary to popular belief, according to research published in the Journal of Sexual Medicine. The authors of the research, from the University of Kentucky and Indiana University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.